Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Breast Neoplasms, Date of authorisa...

 

 
 
 
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Breast Neoplasms, Date of authorisation: 26/09/2018, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Breast Neoplasms, Date of authorisation: 26/09/2018, Revision: 7, Status: Authorised



 
 
 
Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Hemophilia B, Date of authorisation: 02/06/2017, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Hemophilia B, Date of authorisation: 02/06/2017, Revision: 2, Status: Authorised



 
 
 
Human medicines highlights - March 2022
Human medicines highlights - March 2022


Actueel zorgnieuws in jouw mailbox ontvangen?
Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.